Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2020 | Oct. 05, 2021 | Jun. 30, 2019 | |
Document Information Line Items | |||
Entity Registrant Name | Apex 11 Inc. | ||
Document Type | 10-K/A | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Common Stock, Shares Outstanding | 25,927,384 | ||
Entity Public Float | $ 0 | ||
Amendment Flag | true | ||
Amendment Description | Apex 11, Inc. (“we,” “us,” or the “Company”) is filing this Amendment No. 1 to our Form 10-K for the fiscal year ended December 31, 2020, originally filed with the Securities and Exchange Commission on October 12, 2021, for the sole purpose to include the date of the Haynie & Company’s REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. Due to a clerical error this date was omitted. This amended filing includes the date of October 12, 2021.
This Amendment No. 1 speaks as of the original filing date of the Form 10-K and reflects only the changes to the cover page, and Item 8. No other information included in the Form 10-K, including the other information set forth, has been modified or updated in any way. | ||
Entity Central Index Key | 0001578329 | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Well-known Seasoned Issuer | No | ||
Document Period End Date | Dec. 31, 2020 | ||
Document Fiscal Year Focus | 2020 | ||
Document Fiscal Period Focus | FY | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | true | ||
Document Annual Report | true | ||
Entity Interactive Data Current | No |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
TOTAL ASSETS | $ 0 | $ 0 |
CURRENT LIABILITES | ||
Accrued Liabilities | 4,699 | 0 |
STOCKHOLDERS (DEFICIENCY) | ||
Preferred stock; $.0001 par value; 5,000,000 shares authorized; none issued and outstanding | 0 | 0 |
Common stock; $.0001 par value; 100,000,000 shares authorized; 25,927,384 and 21,534,014 issued and outstanding, respectively | 2,592 | 2,153 |
Additional paid-in capital | 87,485 | 67,750 |
Accumulated deficit | (94,776) | (69,903) |
Total stockholders' (deficiency) | (4,699) | 0 |
Total liabilities and stockholders' (deficiency) | $ 0 | $ 0 |
BALANCE SHEETS (Parentheticals)
BALANCE SHEETS (Parentheticals) - $ / shares | Dec. 31, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
Preferred stock par value (in Dollars per share) | $ 0.0001 | $ 0 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 25,927,384 | 21,534,014 |
Common stock, shares outstanding | 25,927,384 | 21,534,014 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
OPERATING EXPENSES | ||
General and administrative | $ 24,873 | $ 27,997 |
NET LOSS | $ (24,873) | $ (27,997) |
Basic and diluted loss per common share (in Dollars per share) | $ 0 | $ 0 |
Basic and diluted weighted-average common shares outstanding (in Shares) | 21,546,051 | 15,663,344 |
STATEMENTS OF STOCKHOLDERS' EQU
STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balances at Dec. 31, 2018 | $ 1,565 | $ 41,307 | $ (41,906) | $ 966 |
Balances (in Shares) at Dec. 31, 2018 | 15,647,216 | |||
Sale of common stock | $ 588 | 26,443 | $ 27,031 | |
Sale of common stock (in Shares) | 5,886,798 | 5,886,798 | ||
Net loss | (27,997) | $ (27,997) | ||
Balances at Dec. 31, 2019 | $ 2,153 | 67,750 | (69,903) | $ 0 |
Balances (in Shares) at Dec. 31, 2019 | 21,534,014 | 21,534,014 | ||
Issuance of common stock in settlement of stockholder payable | $ 439 | 19,735 | $ 20,174 | |
Issuance of common stock in settlement of stockholder payable (in Shares) | 4,393,370 | |||
Sale of common stock | $ 20,174 | |||
Sale of common stock (in Shares) | 4,393,370 | |||
Net loss | (24,873) | $ (24,873) | ||
Balances at Dec. 31, 2020 | $ 2,592 | $ 87,485 | $ (94,776) | $ (4,699) |
Balances (in Shares) at Dec. 31, 2020 | 25,927,384 | 25,927,384 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
OPERATING ACTIVITIES | ||
Net loss | $ (24,873) | $ (27,997) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Repayment of controlling stockholder payable | 0 | 1,042 |
Changes in operating assets and liabilities: | ||
Accrued liabilities | 24,873 | 26,955 |
CASH FLOWS FROM OPERATING ACTIVITIES | 24,873 | 27,997 |
NET CHANGE IN CASH AND CASH EQUIVALENTS | 0 | 0 |
CASH AND CASH EQUIVALENTS, Beginning of year | 0 | 0 |
CASH AND CASH EQUIVALENTS, End of year | 0 | 0 |
NON CASH FINANCING ACTIVITY | ||
Issuance of common stock in settlement of Accrued liabilities | $ 20,174 | $ 27,031 |
ORGANIZATION AND SUMMARY OF SIG
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | 1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Cash and Cash Equivalents Revenue Recognition Earnings (Loss) Per Share Income Taxes The Company accounts for any uncertainty in income taxes by recognizing the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and are often ambiguous. As such, the Company is required to make subjective assumptions and judgments regarding income tax exposures. Interpretations of and guidance surrounding income tax law and regulations change over time and may result in changes to the Company's subjective assumptions and judgments which can materially affect amounts recognized in the financial statements. The Company believes that it does not have any uncertain tax positions that are material to the financial statements. Use of Estimates Going Concern Subsequent Events |
STOCKHOLDERS' DEFICIENCY
STOCKHOLDERS' DEFICIENCY | 12 Months Ended |
Dec. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] | 2. STOCKHOLDERS' (DEFICIENCY) Preferred Stock – The Company is authorized to issue 5,000,000 shares of $.0001 par value preferred stock. As of December 31, 2020 and 2019, no shares of preferred stock have been issued. Common Stock – The Company is authorized to issue 100,000,000 shares of $.0001 par value common stock. As of December 31, 2020 and 2019, 25,927,384 and 21,534,014 shares were issued and outstanding, respectively. During the year ended December 31, 2020, the Company issued 4,393,370 shares of common stock to its controlling stockholder for settlement of $20,174 of accrued liabilities. During the year ended December 31, 2019, the Company sold 5,886,798 shares of common stock to its controlling stockholder for settlement of $27,031 of accrued liabilities. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | 3. INCOME TAXES Significant components of the Company's deferred income tax assets and liabilities are as follows at December 31: 2020 2019 Deferred income tax asset – net operating loss carryforward $ 24,547 $ 18,105 Valuation allowance (24,547 ) (18,105 ) Net deferred income tax asset $ — $ — At December 31, 2020, the Company had approximately $95,000 of net operating loss (NOL) carryforwards available to offset future taxable income, which begin to expire in 2033. However, a valuation allowance has been recorded reducing the NOL net deferred tax asset to zero because of uncertainty as to the ultimate utilization of the net operating losses to which it relates. The valuation allowance increased by $6,442 and $12,242 in 2020 and 2019, respectively. The income tax benefit differed from the amount computed using the statutory federal rate of 21% due primarily to the change in the valuation allowance during 2020 and 2019. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Dec. 31, 2020 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | 4. SUBSEQUENT EVENTS The Company has evaluated subsequent events pursuant to ASC Topic 855 from the balance sheet date through the date the financial statements were issued and determined there are no events to disclose. On January 30, 2020, the World Health Organization declared the coronavirus outbreak a “Public Health Emergency of International Concern” and on March 10, 2020, declared it to be a pandemic. Actions taken around the world to help mitigate the spread of the coronavirus include restrictions on travel, and quarantines in certain areas, and forced closures for certain types of public places and businesses. The coronavirus and actions taken to mitigate it have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates. While it is unknown how long these conditions will last and what the complete financial effect will be to the company, the Company is anticipating potential reductions in revenue, labor and supply shortages, difficulty meeting debt covenants, delays in collecting accounts receivable and paying liabilities and changes in the fair value of assets and liabilities. Additionally, it is reasonably possible that estimates made in the financial statements have been, or will be, materially and adversely impacted in the near term as a result of these conditions, including potential credit losses on receivables and investments; impairment losses related to capitalized gaming assets and other long-lived assets; and contingent obligations. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Organization |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents |
Revenue [Policy Text Block] | Revenue Recognition |
Earnings Per Share, Policy [Policy Text Block] | Earnings (Loss) Per Share |
Income Tax, Policy [Policy Text Block] | Income Taxes The Company accounts for any uncertainty in income taxes by recognizing the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and are often ambiguous. As such, the Company is required to make subjective assumptions and judgments regarding income tax exposures. Interpretations of and guidance surrounding income tax law and regulations change over time and may result in changes to the Company's subjective assumptions and judgments which can materially affect amounts recognized in the financial statements. The Company believes that it does not have any uncertain tax positions that are material to the financial statements. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates |
Going Concern, Policy [Policy Textblock} | Going Concern |
Subsequent Events, Policy [Policy Text Block] | Subsequent Events |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | Significant components of the Company's deferred income tax assets and liabilities are as follows at December 31: 2020 2019 Deferred income tax asset – net operating loss carryforward $ 24,547 $ 18,105 Valuation allowance (24,547 ) (18,105 ) Net deferred income tax asset $ — $ — |
STOCKHOLDERS' DEFICIENCY (Detai
STOCKHOLDERS' DEFICIENCY (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Stockholders' Equity Note [Abstract] | ||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.0001 | $ 0 |
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred Stock, Shares Authorized | 5,000,000 | 5,000,000 |
Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Common Stock, Shares, Issued | 25,927,384 | 21,534,014 |
Common Stock, Shares, Outstanding | 25,927,384 | 21,534,014 |
Stock Issued During Period, Shares, New Issues | 4,393,370 | 5,886,798 |
Stock Issued During Period, Value, New Issues (in Dollars) | $ 20,174 | $ 27,031 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | ||
Operating Loss Carryforwards | $ 95,000 | |
Deferred Tax Assets, Net of Valuation Allowance | 0 | $ 0 |
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | $ 6,442 | $ 12,242 |
Effective Income Tax Rate Reconciliation, Percent | 21.00% |
INCOME TAXES (Details) - Schedu
INCOME TAXES (Details) - Schedule of Deferred Tax Assets and Liabilities - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Schedule of Deferred Tax Assets and Liabilities [Abstract] | ||
Deferred income tax asset – net operating loss carryforward | $ 24,547 | $ 18,105 |
Valuation allowance | (24,547) | (18,105) |
Net deferred income tax asset | $ 0 | $ 0 |